Perma‑Fix Environmental Services, Inc. reported fourth‑quarter 2025 results that showed a 6.9% year‑over‑year increase in revenue to $15.7 million, but the company posted a net loss of $5.7 million and an earnings‑per‑share loss of $0.31. The loss per share missed the consensus estimate of a $0.09 loss by $0.22, and revenue fell $2.4 million short of the $18.1 million analysts expected.
The company’s treatment segment drove the revenue growth, with revenue rising 29% to $11.4 million, while the services segment contracted 26.4% to $4.3 million. Backlog in the treatment segment grew 51% year‑over‑year to $11.9 million, and international revenue surged 163% to $6.4 million. The company’s gross profit margin over the last twelve months was 8.83%, reflecting higher labor and maintenance costs in the treatment segment and lower revenue and margin projects in the services segment.
"During 2025, we focused on strengthening Perma‑Fix’s operational foundation and positioning the Company for the next phase of growth tied to the U.S. Department of Energy’s (DOE) Hanford cleanup mission," said President and CEO Mark Duff. "While the timing of certain government programs affected activity levels during the year, we continued to progress in preparing our facilities, workforce, and infrastructure to support the increased waste volumes expected as the Direct‑Feed Low‑Activity Waste, or DFLAW, program transitions into its operational phase."
The company also renewed the permit for its Perma‑Fix Northwest (PFNW) facility, which became effective on January 1 2026. The renewal tripled the facility’s liquid mixed‑waste processing capacity to approximately 1.2 million gallons per year, providing a clear path for future growth and reinforcing the company’s ability to support long‑term cleanup missions at major nuclear sites.
Management guided for a positive earnings‑per‑share figure by the second quarter of 2026, citing the expected ramp‑up of the DFLAW program, the expanded PFNW capacity, and the company’s PFAS destruction technology. The guidance signals confidence that the company’s backlog and strategic investments will translate into profitability, despite the current net loss and the company’s heavy reliance on federal contracts (63.6% of revenue). The company’s Altman Z‑Score of 2.57 indicates potential financial stress, but the growing backlog and international revenue growth suggest a trajectory toward improved financial health.
The earnings miss was largely driven by higher operating costs in the treatment segment and a decline in services revenue, partly due to the temporary U.S. federal government shutdown in October 2025. Nevertheless, the strong performance in the treatment segment and the significant backlog expansion position Perma‑Fix to capture future opportunities in the Hanford cleanup mission and the growing demand for PFAS‑destruction services.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.